Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Catalys Pacific Fund, LP

At a glance: Catalys Pacific Fund, LP is 10% Owner at Mineralys Therapeutics (MLYS). Their latest SEC Form 4, filed Nov 21, 2025, reported a sale of $43.4M. On file: 0 purchase lines ($0) and 1 sale line ($43.4M).

Disclosed holdings: about $114M of MLYS stock: 7,903,838 shares (including shares held indirectly, e.g. through a trust or fund) reported on its latest Form 4 (filed Nov 21, 2025), valued at the Nov 19, 2026 close of $14.43. This counts only MLYS shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

10% Owner at Mineralys Therapeutics, Inc. (MLYS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $43.4M

Reported trades

Filed Stock Type Shares Price Value Since
Nov 21SEC MLYSMineralys Therapeutics, Inc. Sell 1,000,0007,903,838 held (−11%) $43.35 $43.4M -66.7%

Follow Catalys Pacific Fund, LP

Get one email when Catalys Pacific Fund, LP files a new purchase or sale. Free.

At most one email a day about Catalys Pacific Fund, LP, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.